Publication: Active site contribution to specificity of the aspartic proteases plasmepsins I and II
1
Issued Date
2002-10-25
Resource Type
ISSN
00219258
Other identifier(s)
2-s2.0-0037175033
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Biological Chemistry. Vol.277, No.43 (2002), 41009-41013
Suggested Citation
Pilaiwan Siripurkpong, Jirundon Yuvaniyama, Prapon Wilairat, Daniel E. Goldberg Active site contribution to specificity of the aspartic proteases plasmepsins I and II. Journal of Biological Chemistry. Vol.277, No.43 (2002), 41009-41013. doi:10.1074/jbc.M204852200 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/20036
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Active site contribution to specificity of the aspartic proteases plasmepsins I and II
Other Contributor(s)
Abstract
Plasmepsins I and II (PM I and II) are aspartic proteases involved in the initial steps of Plasmodium hemoglobin degradation. They are attractive targets for antimalarial drug development. The two enzymes are 73% identical, yet have different substrate and inhibitor specificities. The x-ray structures of proform and mature PM II have been determined, but models of PM I do not adequately explain the selectivity of the two proteases. To better understand the basis of these recognition differences, we have identified nine residues of PM II that are in proximity to the inhibitor pepstatin in the crystal structure and differ in PM I. We mutated these residues in PM II to the cognate amino acids of PM I. Kinetic parameters for substrate and inhibitors for the PM II-mutant were similar to those of PM II-wild type (WT). Cleavage specificity was assessed using hemoglobin or a random decamer peptide library as substrate. Again, PM II-mutant behaved like PM II-WT rather than PM I-WT. These results indicate that differences in plasmepsin specificity depend more on conformational differences from distant sites than on specific active site variation.